Comparison of two different doses of Buprenorphine patch for post operative analgesia in patients of Abdominal surgeries.

COMPARISON OF TWO DIFFERENT DOSES OF BUPRENORPHINE PATCH FOR POST OPERATIVE ANALGESIA IN PATIENTS OF ABDOMINAL SURGERIES - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105412

Enrollment

150

Registered

2026-03-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R10-R19- Symptoms and signs involving the digestive system and abdomen

Interventions

Intervention1: Buprenorphine patch: Dose-10 mg and 20 mg buprenorphine patch Route of administration-transdermal Total duration-pod 7 Intervention2: Nil: Nil Control Intervention1: Placebo patch: Dose

Eligibility

Inclusion criteria

Inclusion criteria: Asa Grade 1 AND 2 Patients. All patients undergoing elective abdominal surgeries under general anaesthesia All patients willing to give informed and written consent

Exclusion criteria

Exclusion criteria: ASA GRADE 3 OR HIGHER, LACK OF CONSENT, PREGNANT LADIES, PATIENTS WITH HISTORY OF ALLERGY TO DRUG USED, PATIENTS WITH PSYCHIATRIC ILLNESS

Design outcomes

Primary

Measure	Time frame
To evaluate the onset and duration of postoperative analgesia provided by buprenorphine transdermal patch (10mg and 20 mg) in abdominal surgeries. Timepoint: 2 YEARS	—

Secondary

Measure	Time frame
To evaluate hemodynamics postoperatively To assess side effects Total number of rescue analgesia required between two groups. Assess patient satisfactionTimepoint: 2 YEARS	—

Countries

India

Contacts

Public ContactDr Vivek Chakole

Jawaharlal Nehru medical college

hod.anesthesiajnmc@gmail.com7583836564

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026